Thalamus damage plays key role in long-term stroke disability

A recent study from Simon Fraser University researchers has revealed how an overlooked type of indirect brain damage contributes to ongoing disability after a stroke.

Seventh patient ‘cured’ of HIV among highlights at AIDS 2024

The 25th International AIDS conference will take place in Munich, Germany, between 22 and 26 July. Image credit: Shutterstock / wavebreakmedia. Researchers will present data

July 19, 2024

FDA approves omalizumab for food allergy reactions based on NIH research

Today’s Food and Drug Administration approval of a supplemental biologics license for the monoclonal antibody omalizumab (Xolair) highlights the vital role of the National Institutes

February 17, 2024

BridgeBio Oncology and Helix enter definitive merger agreement

BBOT’s BBO-8520 is currently undergoing the Phase I ONKORAS-101 trial. Credit: CrizzyStudio/Shutterstock. BridgeBio Oncology has entered a definitive merger agreement with Helix Acquisition Corp II,

March 3, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.